RNS Number : 3248I Optima Health PLC 16 October 2024 16 October 2024 Optima Health plc ("Optima Health" or the "Company") Director / PDMR Shareholdings Optima Health plc (AIM: OPT), the UK's leading provider of technology enabled corporate health and wellbeing solutions, announces the following transactions in the Company's Ordinary Shares were undertaken by Persons Discharging Managerial Responsibilities. The Company was notified on 14 October 2024, that Joanne Newey, a PDMR of the Company, (Group Business Development & Propositions Director) purchased 12,500 ordinary shares of £0.01 in the Company ("Ordinary Shares") at a price of 159 pence per share. Following this, Joanne Newey holds an interest of 70,034 Ordinary Shares, representing approximately 0.08% of the current issued share capital. The Company was notified on 15 October 2024, that Heidi Giles, an Executive Director of the Company, (Chief Financial Officer) purchased 12,194 ordinary shares of £0.01 in the Company ("Ordinary Shares") at a price of 163.95 pence per share. Following this, Heidi Giles holds an interest of 69,728 Ordinary Shares, representing approximately 0.08% of the current issued share capital. Contacts: About Optima Health Optima Health is the UK's leading provider of occupational health and wellbeing services, directly influencing and improving people's lives for 25 years. Optima Health's incredible team of professionals quickly and effectively encapsulate client's needs, supporting organisations of all shapes and sizes. Through tailored solutions and innovative systems, Optima Health offers unparalleled clinical expertise to its clients. These solutions ensure that processes are simple and allow its clients to spend more time focusing on their employees driving a healthy, high-performing workplace. For more information visit www.optima health.co.uk NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com. RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END DSHFFAEFIELSEIS